The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Prescription Headache Medicine Market Research Report 2024

Global Prescription Headache Medicine Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1766140

No of Pages : 87

Ask Your Query

Synopsis
Prescription headache medicines are medications that require a prescription from a healthcare professional to obtain. These medicines are typically used for the treatment of moderate to severe headaches or migraines that may not be effectively relieved by over-the-counter options.

Global Prescription Headache Medicine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prescription Headache Medicine market research.

Headaches and migraines are common conditions affecting a significant portion of the population. The increasing prevalence of these conditions drives the demand for prescription headache medicines as individuals seek effective treatment options to manage their symptoms. While over-the-counter medications can provide relief for many individuals with mild headaches, there is a substantial population that experiences moderate to severe headaches or migraines that require stronger prescription medications. The unmet medical needs of this population drive the demand for prescription headache medicines.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Prescription Headache Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • GSK
  • Teva
  • Pfizer
  • Amgen
  • Viatris
  • Allergan
  • Grunenthal
  • Eli Lilly

Segment by Type

  • Sumatriptan
  • Rizatriptan
  • Others

Segment by Application

  • Hospital
  • Clinic
  • Drug Store

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Prescription Headache Medicine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prescription Headache Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Sumatriptan
1.2.3 Rizatriptan
1.2.4 Others
1.3 Market by Application
1.3.1 Global Prescription Headache Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prescription Headache Medicine Market Perspective (2018-2029)
2.2 Prescription Headache Medicine Growth Trends by Region
2.2.1 Global Prescription Headache Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prescription Headache Medicine Historic Market Size by Region (2018-2023)
2.2.3 Prescription Headache Medicine Forecasted Market Size by Region (2024-2029)
2.3 Prescription Headache Medicine Market Dynamics
2.3.1 Prescription Headache Medicine Industry Trends
2.3.2 Prescription Headache Medicine Market Drivers
2.3.3 Prescription Headache Medicine Market Challenges
2.3.4 Prescription Headache Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prescription Headache Medicine Players by Revenue
3.1.1 Global Top Prescription Headache Medicine Players by Revenue (2018-2023)
3.1.2 Global Prescription Headache Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Prescription Headache Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prescription Headache Medicine Revenue
3.4 Global Prescription Headache Medicine Market Concentration Ratio
3.4.1 Global Prescription Headache Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prescription Headache Medicine Revenue in 2022
3.5 Prescription Headache Medicine Key Players Head office and Area Served
3.6 Key Players Prescription Headache Medicine Product Solution and Service
3.7 Date of Enter into Prescription Headache Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prescription Headache Medicine Breakdown Data by Type
4.1 Global Prescription Headache Medicine Historic Market Size by Type (2018-2023)
4.2 Global Prescription Headache Medicine Forecasted Market Size by Type (2024-2029)
5 Prescription Headache Medicine Breakdown Data by Application
5.1 Global Prescription Headache Medicine Historic Market Size by Application (2018-2023)
5.2 Global Prescription Headache Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prescription Headache Medicine Market Size (2018-2029)
6.2 North America Prescription Headache Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prescription Headache Medicine Market Size by Country (2018-2023)
6.4 North America Prescription Headache Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prescription Headache Medicine Market Size (2018-2029)
7.2 Europe Prescription Headache Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prescription Headache Medicine Market Size by Country (2018-2023)
7.4 Europe Prescription Headache Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prescription Headache Medicine Market Size (2018-2029)
8.2 Asia-Pacific Prescription Headache Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prescription Headache Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Prescription Headache Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prescription Headache Medicine Market Size (2018-2029)
9.2 Latin America Prescription Headache Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prescription Headache Medicine Market Size by Country (2018-2023)
9.4 Latin America Prescription Headache Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prescription Headache Medicine Market Size (2018-2029)
10.2 Middle East & Africa Prescription Headache Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prescription Headache Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Prescription Headache Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Prescription Headache Medicine Introduction
11.1.4 GSK Revenue in Prescription Headache Medicine Business (2018-2023)
11.1.5 GSK Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Prescription Headache Medicine Introduction
11.2.4 Teva Revenue in Prescription Headache Medicine Business (2018-2023)
11.2.5 Teva Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Prescription Headache Medicine Introduction
11.3.4 Pfizer Revenue in Prescription Headache Medicine Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Prescription Headache Medicine Introduction
11.4.4 Amgen Revenue in Prescription Headache Medicine Business (2018-2023)
11.4.5 Amgen Recent Development
11.5 Viatris
11.5.1 Viatris Company Detail
11.5.2 Viatris Business Overview
11.5.3 Viatris Prescription Headache Medicine Introduction
11.5.4 Viatris Revenue in Prescription Headache Medicine Business (2018-2023)
11.5.5 Viatris Recent Development
11.6 Allergan
11.6.1 Allergan Company Detail
11.6.2 Allergan Business Overview
11.6.3 Allergan Prescription Headache Medicine Introduction
11.6.4 Allergan Revenue in Prescription Headache Medicine Business (2018-2023)
11.6.5 Allergan Recent Development
11.7 Grunenthal
11.7.1 Grunenthal Company Detail
11.7.2 Grunenthal Business Overview
11.7.3 Grunenthal Prescription Headache Medicine Introduction
11.7.4 Grunenthal Revenue in Prescription Headache Medicine Business (2018-2023)
11.7.5 Grunenthal Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Prescription Headache Medicine Introduction
11.8.4 Eli Lilly Revenue in Prescription Headache Medicine Business (2018-2023)
11.8.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock